Screening for colorectal cancer.
Randomized, controlled trials have shown with certainty that screening for colorectal cancer reduces morbidity and is cost-effective. Factors that increase the risk of colorectal cancer include a personal or family history of adenomatous polyps or colorectal cancer, certain genetic syndromes and chronic inflammatory bowel disease.
Jednak
M A
MA
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0362, USA.
Nostrant
T T
TT
D011125:Adenomatous Polyposis Coli / Q000150:complications; D001466:Barium Sulfate; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D004733:Enema; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D008403:Mass Screening / Q000191:economics / Q000379:methods*; D009780:Occult Blood; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014481:United States / Q000453:epidemiology
D001466:Barium Sulfate